Harmony Biosciences Holdings, Inc. provided revenue guidance for the year 2025. For the year, the company net revenue projected between $820 million to $860 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.98 USD | -0.24% |
|
+4.09% | +13.28% |
Feb. 11 | Deutsche Bank Initiates Coverage on Harmony Biosciences With Buy Rating, $55 Price Target | MT |
Feb. 03 | BofA Adjusts Price Target on Harmony Biosciences to $31 From $32 | MT |

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Harmony Biosciences Holdings, Inc. Provides Revenue Guidance for the Year 2025